PLYMOUTH, MN – January 11, 2017 – Cantel Medical Corp. (NYSE:CMD) is pleased to announce that its subsidiary, Mar Cor Purification, a market leader in purified water systems, has entered into an agreement with RephiLe Biosciences, Ltd. to distribute their laboratory water systems to customers in North America. These systems are used in research facilities, universities, hospitals and other critical high purity, low volume applications. The broad line of systems are capable of producing various grades of high purity water used in lab, research, blood analyzers and other grades of water.

“The RephiLe line of laboratory systems are designed to meet the increasing requirements of our customers by providing technically advanced, innovative systems coupled with a robust design,” stated Christopher Fournier, VP Marketing, Mar Cor. “Our direct sales force of over 50 professional sales people will have full access to the entire product line in order to address the specialized capacity requirements of the laboratory market.”

Peter Lucas, President, North America, RephiLe Biosciences stated, “Mar Cor provides unparalleled support to its water purification customers from a sales and service perspective. With Mar Cor’s 30 service and regeneration centers across North America, coupled with experienced sales and service teams, our customers will have coverage for installation, service, and maintenance of RephiLe Biosciences water purification systems. This agreement continues to build upon our strategic and tactical expansion in North America to offer our customers outstanding products and support.”